Your browser doesn't support javascript.
loading
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
Schuetze, Scott M; Bolejack, Vanessa; Thomas, Dafydd G; von Mehren, Margaret; Patel, Shreyaskumar; Samuels, Brian; Choy, Edwin; D'Amato, Gina; Staddon, Arthur P; Ganjoo, Kristen N; Chow, Warren A; Rushing, Daniel A; Forscher, Charles A; Priebat, Dennis A; Loeb, David M; Chugh, Rashmi; Okuno, Scott; Reinke, Denise K; Baker, Laurence H.
Afiliação
  • Schuetze SM; Department of Internal Medicine, University of Michigan, Ann Arbor.
  • Bolejack V; Cancer Research and Biostatistics, Seattle, Washington.
  • Thomas DG; Department of Pathology, University of Michigan, Ann Arbor.
  • von Mehren M; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Patel S; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
  • Samuels B; Summit Cancer Centers, Post Falls, Idaho.
  • Choy E; Department of Medicine, Massachusetts General Hospital, Boston.
  • D'Amato G; Georgia Cancer Specialists, Sandy Springs.
  • Staddon AP; Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
  • Ganjoo KN; Department of Medicine, Stanford Cancer Institute, Stanford, California.
  • Chow WA; Department of Medical Oncology and Therapeutics Research, City of Hope Medical Center, Duarte, California.
  • Rushing DA; Department of Medicine, Indiana University, Indianapolis.
  • Forscher CA; Cedars-Sinai Medical Center, Los Angeles, California.
  • Priebat DA; Medstar Washington Hospital Center, Washington, DC.
  • Loeb DM; Department of Pediatrics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.
  • Chugh R; Department of Internal Medicine, University of Michigan, Ann Arbor.
  • Okuno S; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Reinke DK; Sarcoma Alliance for Research Through Collaboration, Ann Arbor, Michigan.
  • Baker LH; Department of Internal Medicine, University of Michigan, Ann Arbor.
JAMA Oncol ; 4(6): 814-820, 2018 06 01.
Article em En | MEDLINE | ID: mdl-29710216
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Mesilato de Imatinib / Dasatinibe / Neoplasias Gastrointestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Mesilato de Imatinib / Dasatinibe / Neoplasias Gastrointestinais / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Ano de publicação: 2018 Tipo de documento: Article